Aptitude aérobie sous-maximale et qualité de vie des fumeurs exclusifs de narguilé

Saad, Helmi Ben; Babba, Maya; Boukamcha, Rafik; Latiri, Imed; Knani, J.; Slama, Rémy; Bougmiza, Iheb; Zbidi, A.; Tabka, Zouhaïr

doi:10.1016/j.rmr.2010.03.009

Cited by 7 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Completion of the evaluation with a bronchial reversibility test (46) and/or measurement of diffusing capacity for CO (47) would also have been useful. Similarly, it would have been useful to perform, as part of disability and handicap evaluation, a walk test and a quality of life questionnaire (48). In this study, we focused only on the purely functional aspects of exclusive narghile use.…”

Section: Discussionmentioning

confidence: 99%

Pulmonary functions of narghile smokers compared to cigarette smokers: a case–control study

Saad

Khemiss

Nhari

et al. 2013

Libyan Journal of Medicine

View full text Add to dashboard Cite

BackgroundStudies of the lung function profiles of exclusive narghile smokers (ENS) are few, have some methodological limits, and present contradictory conclusions. The present study aimed to compare the plethysmographic profiles of ENS with age- and height-matched exclusive cigarette smokers (ECS).MethodsMales aged 35–60 living in Sousse, Tunisia, who have been smoking narghile exclusively for more than 10 narghile-years (n=36) or cigarettes exclusively for more than 10 pack-years (n=106) were recruited to participate in this case–control study. The anthropometric and plethysmographic data were measured according to international recommendations using a body plethysmograph (ZAN 500 Body II, Meβgreräte GmbH, Germany). Large-airway-obstructive-ventilatory-defect (LAOVD) was defined as: first second forced expiratory volume/forced vital capacity (FEV1/FVC) below the lower-limit-of-normal (LLN). Restrictive-ventilatory-defect (RVD) was defined as total lung capacity < LLN. Lung hyperinflation was defined as residual volume > upper-limit-of-normal. Student t-test and χ2 test were used to compare plethysmographic data and profiles of the two groups.ResultsThe subjects in the ENS and ECS groups are well matched in age (45±7 vs. 47±5 years) and height (1.73±0.06 vs. 1.72±0.06 m) and used similar quantities of tobacco (36±22 narghile-years vs. 35±19 pack-years). Compared to the ENS group, the ECS group had significantly lower FEV1 (84±12 vs. 60±21%), FVC (90±12 vs. 76±18%), and FEV1/FVC (99±7 vs. 83±17%). The two groups had similar percentages of RVD (31 vs. 36%), while the ECS group had a significantly higher percentage of LAOVD (8 vs. 58%) and lung hyperinflation (36 vs.57%).ConclusionChronic exclusive narghile smoking has less adverse effects on pulmonary function tests than chronic exclusive cigarette smoking.

show abstract

Section: Discussionmentioning

confidence: 99%

Pulmonary functions of narghile smokers compared to cigarette smokers: a case–control study

Saad

Khemiss

Nhari

et al. 2013

Libyan Journal of Medicine

View full text Add to dashboard Cite

show abstract

“…These two CGs were recruited as a part of current protocols aiming to evaluate the submaximal exercise capacity of narghile smokers17 and obstructive-sleep-apnea patients 18…”

Section: Population and Methodsmentioning

confidence: 99%

Six-minute walk test in non-insulin-dependent diabetes mellitus patients living in Northwest Africa

Latiri¹,

Elbey²,

Hcini³

et al. 2012

DMSO

View full text Add to dashboard Cite

IntroductionInternational recommendations of the exploration of non-insulin-dependent diabetes mellitus (NIDDM) are focused on deficiency and not incapacity.Aims(1) To estimate the incapacity of NIDDM patients through the 6-minute walk test (6MWT) data. (2) To determine their 6-minute walk distance (6MWD) influencing factors (3) To compare data of NIDDM patient group (PG; n = 100) with those of two control groups (CG): CG1 (n = 174, healthy nonobese and nonsmoker); CG2 (n = 55, obese nondiabetic free from comorbidities).Population and methodsThe anthropometric, socioeconomic, clinical, metabolic, and 6MWT data of 100 NIDDM patients (45 females) were collected.ResultsTotal sample means ± standard deviation of age, weight, and height were 54 ± 8 years, 81 ± 14 kg, and 1.64 ± 0.09 m. (1) Measured 6MWD (566 ± 81 m) was significantly lower than the theoretical 6MWD (90% ± 12%). The profile of the PG carrying the 6MWT, was as follows: 23% had an abnormal 6MWD; at the end of the 6MWT, 21% and 12% had, respectively, a low heart rate and a high dyspnea (>5/10), and 4% had desaturation during the walk. The estimated “cardiorespiratory and muscular chain” age (68 ± 16 years) was significantly higher than the chronological age. (2) The factors that significantly influenced the 6MWD (r2 = 0.58) are included in the following equation: 6MWD (m) = −73.94 × gender (0, male; 1, female) – 3.25 × age (years) + 7.33 × leisure activity score – 35.57 × obesity (0, no; 1, yes) + 32.86 × socioeconomic level (0, low; 1, high) – 27.67 × cigarette use (0, no; 1, yes) + 8.89 × resting oxyhemoglobin saturation – 105.48. (3) Compared to the CGs, the PG had a significantly (P < 0.05) lower 6MWD (100%+9% and 100%+8%, respectively, for the CG1 and CG2).ConclusionNIDDM seems to accelerate the decline of the submaximal aerobic capacity evaluated through the 6MWD.

show abstract

Aptitude aérobie sous-maximale et qualité de vie des patients atteints de polyarthrite rhumatoïde

Lataoui

Belghali

Zeglaoui

et al. 2017

Revue des Maladies Respiratoires

View full text Add to dashboard Cite

Aptitude aérobie sous-maximale et qualité de vie des fumeurs exclusifs de narguilé

Cited by 7 publications

References 18 publications

Pulmonary functions of narghile smokers compared to cigarette smokers: a case–control study

Pulmonary functions of narghile smokers compared to cigarette smokers: a case–control study

Six-minute walk test in non-insulin-dependent diabetes mellitus patients living in Northwest Africa

Aptitude aérobie sous-maximale et qualité de vie des patients atteints de polyarthrite rhumatoïde

Contact Info

Product

Resources

About